Answers are grounded in this paper and cite their sources.
It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA
No takes yet. Share an insight, caveat, or question.
Erick H. Turner (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: